Faculty

Joanne Stekler

Adjunct Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Adjunct Professor, Global Health

206-744-8312
jstekler@uw.edu

Education

BA Biology, Williams College, 1992
MD Medicine (MD), Duke University, 1997
MPH Epidemiology, University of Washington, 2004

Contact

206-744-8312
jstekler@uw.edu

University of Washington
Box 359931
Division of Allergy & Infectious Diseases
Harborview Medical Center
325 Ninth Avenue
Seattle, WA 98104

Research Areas

Research Interests

Dr. Joanne Stekler's research centers on HIV testing and HIV prevention. She is a national expert on HIV tests, particularly focused on acute HIV infection and point-of-care testing. She started the first community-based clinic for HIV pre-exposure prophylaxis (PrEP) in Seattle and is currently working to increase access to PrEP and PrEP adherence across Washington State.

Recent Publications (PubMed)

Perceptions of Sexual Risk, PrEP Services, and Peer Navigation Support among HIV-Negative Latinx and Black Men who have Sex with Men (MSM) Residing in Western Washington.
(2022 Sep)
Sex Res Social Policy 19(3): 1058-1068
Jaramillo J, Pagkas-Bather J, Waters K, Shackelford LB, Campbell RD, Henry J, Grandberry V, Ramirez LF, Cervantes L, Stekler J, Andrasik MP, Graham SM

Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
(2022 Nov 1)
Harm Reduct J 19(1): 121
Barry MP, Austin EJ, Bhatraju EP, Glick SN, Stekler JD, Tung EL, Hansen RN, Williams EC, Gojic AJ, Pickering EI, Tsui JI

Baseline HIV genotype drug resistance testing: is it time for more or less?
(2022 Aug 1)
AIDS 36(10): 1449-1451
Wood BR, Stekler JD

Provider perspectives on the use of motivational interviewing and problem-solving counseling paired with the point-of-care nucleic acid test for HIV care.
(2022)
PLoS One 17(6): e0270302
Atkins DL, Violette L, Neimann L, Tanner M, Hoover K, Rao D, Stekler JD

Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).
(2022 Dec)
AIDS Behav 26(12): 4107-4114
Mayer KH, Yuhas K, Amico KR, Wilkin T, Landovitz RJ, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Cottle LM, Marcus C, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Magnus M, Farley JE, Liu AY, Frank I, Ho K, Santana J, Stekler JD, Chen YQ, McCauley M, Gulick RM, HPTN 069/ACTG 5305 Study Team

Show complete publication list